- Home
- IPSC vs NMTC Comparison
IPSC vs NMTC Comparison
Compare IPSC & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- NMTC
- Stock Information
- Founded
- IPSC 2019
- NMTC 2009
- Country
- IPSC United States
- NMTC United States
- Employees
- IPSC N/A
- NMTC N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- NMTC Medical/Dental Instruments
- Sector
- IPSC Health Care
- NMTC Health Care
- Exchange
- IPSC Nasdaq
- NMTC Nasdaq
- Market Cap
- IPSC 49.1M
- NMTC 45.0M
- IPO Year
- IPSC 2021
- NMTC N/A
- Fundamental
- Price
- IPSC $0.56
- NMTC $0.73
- Analyst Decision
- IPSC Strong Buy
- NMTC Strong Buy
- Analyst Count
- IPSC 5
- NMTC 2
- Target Price
- IPSC $3.33
- NMTC $2.23
- AVG Volume (30 Days)
- IPSC 1.4M
- NMTC 347.8K
- Earning Date
- IPSC 11-07-2025
- NMTC 12-16-2025
- Dividend Yield
- IPSC N/A
- NMTC N/A
- EPS Growth
- IPSC N/A
- NMTC N/A
- EPS
- IPSC N/A
- NMTC N/A
- Revenue
- IPSC $114,128,000.00
- NMTC $6,629,051.00
- Revenue This Year
- IPSC $1,589.94
- NMTC $162.84
- Revenue Next Year
- IPSC N/A
- NMTC $26.51
- P/E Ratio
- IPSC N/A
- NMTC N/A
- Revenue Growth
- IPSC 5491.77
- NMTC 69.00
- 52 Week Low
- IPSC $0.34
- NMTC $0.40
- 52 Week High
- IPSC $1.83
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- IPSC 48.92
- NMTC 34.60
- Support Level
- IPSC $0.55
- NMTC $0.70
- Resistance Level
- IPSC $0.65
- NMTC $0.83
- Average True Range (ATR)
- IPSC 0.04
- NMTC 0.05
- MACD
- IPSC -0.00
- NMTC -0.01
- Stochastic Oscillator
- IPSC 18.00
- NMTC 16.74
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.